Tag Archives: Samsung Bioepis

September, 2018

June, 2018

December, 2017

August, 2017

July, 2017

April, 2017

June, 2016

  • 10 June

    Samsung Bioepis Announces New Late-Stage Data on Three Biosimilars

    INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced new clinical data on its anti-TNF-α portfolio of Benepali® (etanercept), Flixabi® (infliximab) and SB5 (adalimumab) investigational biosimilar candidate. The data will be presented through seven poster presentations and an abstract publication at the Annual European Congress on Rheumatology (EULAR 2016), which is …

April, 2016